DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09606 DUALITYBIO-B

Closed 08-19 16:08:48

181.500

-0.900

-0.49%

High185.800	Low178.400	Vol553.00K
Open181.700	D1 Closing182.400	Amplitude4.06%
Mkt Cap16.48B	Tradable Cap16.48B	Total Shares90.82M
T/O100.01M	T/O Rate0.61%	Tradable Shares90.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":181.5,"timestamp":1787126928010,"preClose":182.4,"halted":0,"volume":553002,"delay":0,"changeRate":-0.00493421052631582,"floatShares":90824200,"shares":90824200,"eps":-39.8,"marketStatus":"Closed","change":-0.9,"latestTime":"08-19 16:08:48","open":181.7,"high":185.8,"low":178.4,"amount":100009040,"amplitude":0.04057,"askPrice":181.5,"askSize":1100,"bidPrice":181.3,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-31.631,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787189400000},"marketStatusCode":5,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":182.4,"openAndCloseTimeList":[[1787103000000,1787112000000],[1787115600000,1787126400000]],"volumeRatio":0.683296,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"1163478320","title":"UBS Initiates Coverage on DUALITYBIO-B with \"Buy\" Rating and HK$320 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1163478320","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163478320?lang=en_us&edition=full_marsco","pubTime":"2026-08-17 11:11","pubTimestamp":1786936284,"startTime":"0","endTime":"0","summary":"UBS has initiated coverage on DUALITYBIO-B (09606) with a \"Buy\" rating and a target price of HK$320, based on a risk-adjusted discounted cash flow (DCF) valuation. This target implies a 1.2x...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","EWH","09606","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179220111","title":"Movement Alert｜DUALITYBIO-B Falls 5.14% in Regular Trading, Biotech Sector Under Pressure Amid BioNTech Partnership Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1179220111","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179220111?lang=en_us&edition=full_marsco","pubTime":"2026-08-17 09:53","pubTimestamp":1786931598,"startTime":"0","endTime":"0","summary":"On August 17, DUALITYBIO-B fell 5.14% in regular trading, trading at 182.2 HKD/share, with turnover of approximately 27.98 million HKD. The decline comes amid lingering market concerns over...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"DUALITYBIO-B Falls as Biotech Sector Under Pressure Amid BioNTech Partnership Uncertainty","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112924","title":"Everest Medicines Appoints Yue Wang as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112924","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112924?lang=en_us&edition=full_marsco","pubTime":"2026-08-14 17:05","pubTimestamp":1786698311,"startTime":"0","endTime":"0","summary":"Everest Medicines appoints Yue Wang as non-executive directorEverest Medicines named Yue Wang as a non-executive director, effective Aug. 14, 2026.William Ki Chul Cho resigned as a non-executive direc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL9wlDNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426308.USD","LU1794554557.SGD","HK0000252160.HKD","LU0456827905.SGD","LU2543165471.USD","LU0029874061.USD","09606","02269","BK1576","LU0128526141.USD","LU0359202008.SGD","LU0307460666.USD","LU0181495838.USD","LU0348825331.USD","KURE","LU0140636845.USD","BK1610","LU0320764599.SGD","LU0348735423.USD","LU1242518857.USD","LU0979878070.USD","LU2039709279.SGD","HK0000252152.HKD","LU0516422952.EUR","01952","LU0516422440.USD","LU0043850808.USD","LU0516423091.SGD","LU0417516738.SGD","IE00B0JY6N72.USD","SG9999002463.SGD","LU0516422366.SGD","BK1589","BK1574","LU0039217434.USD","LU0819121731.USD","BK1161","BK1521","LU0572944931.SGD","LU0456846285.SGD","LU0326950275.SGD","LU0327786744.USD","SG9999002562.SGD","LU0052750758.USD","LU0823426480.USD","HK0000500386.USD","LU0359201612.USD","LU0417516902.SGD","LU0588546209.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156090062","title":"Duality Biotherapeutics Schedules 28 Aug 2026 Board Meeting to Review 1H 2026 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1156090062","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156090062?lang=en_us&edition=full_marsco","pubTime":"2026-08-14 16:47","pubTimestamp":1786697272,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113058527","title":"Movement Alert｜DUALITYBIO-B Rises 5.28% in Regular Trading, Biotech Sector Rally Extends Valuation Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1113058527","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113058527?lang=en_us&edition=full_marsco","pubTime":"2026-08-11 11:53","pubTimestamp":1786420387,"startTime":"0","endTime":"0","summary":"On August 11, DUALITYBIO-B rose 5.28% in regular trading, trading at 207.6 HKD/share, with turnover of approximately 106 million HKD. The stock continued its rebound driven by broad-based strength...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179387639","title":"Movement Alert｜DUALITYBIO-B Rises 5.09% in Regular Trading, Biotech Sector Strength Drives Rebound Continuation","url":"https://stock-news.laohu8.com/highlight/detail?id=1179387639","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179387639?lang=en_us&edition=full_marsco","pubTime":"2026-08-07 14:18","pubTimestamp":1786083511,"startTime":"0","endTime":"0","summary":"On August 7, DUALITYBIO-B rose 5.09% in regular trading, trading at 191.6 HKD/share, with turnover of approximately HKD 149 million. The stock had previously plunged 13.7% on July 30 due to GSK...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145921871","title":"DualityBio issues 0.28 million new shares in July; public float remains compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1145921871","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145921871?lang=en_us&edition=full_marsco","pubTime":"2026-08-05 16:49","pubTimestamp":1785919790,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio) filed its July 2026 monthly return, detailing a small increase in issued capital driven by employee option exercises. A total of 0.28 million ordinary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195515429","title":"Movement Alert｜DUALITYBIO-B Rises 5.15% in Regular Trading, Innovative Drug Sector Sentiment Recovery and Breakthrough Therapy Designation Boost Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1195515429","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195515429?lang=en_us&edition=full_marsco","pubTime":"2026-08-04 13:23","pubTimestamp":1785821026,"startTime":"0","endTime":"0","summary":"On August 4, DUALITYBIO-B rose 5.15% in regular trading, trading at 190.0 HKD/share, with turnover of HKD 134 million. The stock staged a notable rebound after consecutive declines of 13.7% on July...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168818191","title":"Movement Alert｜DUALITYBIO-B Falls 5.23% in Regular Trading, GSK Competitive Pressure and Lock-up Expiry Concerns Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=1168818191","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168818191?lang=en_us&edition=full_marsco","pubTime":"2026-08-03 09:45","pubTimestamp":1785721553,"startTime":"0","endTime":"0","summary":"On August 3, DUALITYBIO-B fell 5.23% in regular trading, trading at 171.8 HKD/share with turnover of approximately 28.44 million HKD. The stock continues its downward trajectory following a 13.7%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104410900","title":"Movement Alert｜DotBio-B Falls 5.15% in Regular Trading, Biotech Sector Broadly Weakens After Prior Session Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1104410900","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104410900?lang=en_us&edition=full_marsco","pubTime":"2026-07-21 10:17","pubTimestamp":1784600232,"startTime":"0","endTime":"0","summary":"On July 21, DotBio-B declined 5.15% in regular trading, trading at 230.2 HKD/share, with turnover of approximately HKD 54.22 million. The broader biotechnology sector showed widespread weakness, with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162254238","title":"Hong Kong Market Analysis: Curse Lifted, Stimulus Resumes, Token Concept Stocks Soar","url":"https://stock-news.laohu8.com/highlight/detail?id=1162254238","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162254238?lang=en_us&edition=full_marsco","pubTime":"2026-07-20 21:10","pubTimestamp":1784553010,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market's performance has been commendable recently, having risen for three consecutive weeks. A key factor is the influx of incremental capital: the US has confirmed to China that...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1538","BK1518","LU0320764599.SGD","VXUS","LU0359201612.USD","00991","BK4588","03317","BK1125","BK1594","BK1607","HK0000500386.USD","LU1328277881.USD","BK1517","BK1155","BK1589","HK0000252152.HKD","LU0314109678.HKD","LU0359202008.SGD","LU0052750758.USD","BK1618","BK1163","BK1530","01898","HK0000252160.HKD","KCAI","BK1178","LU0708995583.HKD","BK4585","LU2543165471.USD","LU0051755006.USD","BK1109","LU0359201885.HKD","09606","LU0072462343.USD","LU0456827905.SGD","BK1613","LU1023057109.AUD","LU2039709279.SGD","BK1161","LU1048588211.SGD","IE0034224299.USD","BK1586","LU1813983027.USD","00268","03986","BK1526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139325586","title":"Movement Alert｜DotBio-B Rises 7.07% in Regular Trading, DB-1310 Clinical Data Unveiled at ASCO and Partner Avenzo Completes Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1139325586","media":"Market Focus","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139325586?lang=en_us&edition=full_marsco","pubTime":"2026-07-20 10:32","pubTimestamp":1784514760,"startTime":"0","endTime":"0","summary":"On July 20, DotBio-B rose 7.07% in regular trading, trading at HK$231.4 per share, with turnover of HK$122 million.On the news front, the company recently presented initial Phase I/IIa results for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174474978","title":"Movement Alert｜Duality Biotherapeutics Declines 5.99% in Regular Trading, Trading at HK$220.2","url":"https://stock-news.laohu8.com/highlight/detail?id=1174474978","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174474978?lang=en_us&edition=full_marsco","pubTime":"2026-07-17 10:02","pubTimestamp":1784253754,"startTime":"0","endTime":"0","summary":"On July 17, Duality Biotherapeutics-B (09606.HK) fell 5.99% in regular trading, trading at HK$220.2 per share, with turnover of HK$53.05 million.Within the Biotechnology sector where Duality...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130433920","title":"Movement Alert｜DotBio Rises 5.12% in Regular Trading, A-Share IPO Enters Inquiry Stage Amid HK-to-A Return Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=1130433920","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130433920?lang=en_us&edition=full_marsco","pubTime":"2026-07-15 09:47","pubTimestamp":1784080068,"startTime":"0","endTime":"0","summary":"On July 15, DotBio-B (09606.HK) rose 5.12% in regular trading, trading at HK$233.4/share, with turnover of approximately HK$48.9 million.The rally comes amid sustained momentum from the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650150375","title":"Duality Biotherapeutics Insiders Sold CN¥89m Of Shares Suggesting Hesitancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2650150375","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650150375?lang=en_us&edition=full_marsco","pubTime":"2026-07-12 10:43","pubTimestamp":1783824233,"startTime":"0","endTime":"0","summary":"Many Duality Biotherapeutics, Inc. ( HKG:9606 ) insiders ditched their stock over the past year, which may be of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-insiders-sold-cn89m-of-shares-sugges","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9606/duality-biotherapeutics-shares/news/duality-biotherapeutics-insiders-sold-cn89m-of-shares-sugges","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252152.HKD","09606","CN","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198039714","title":"Movement Alert｜Duality Biotherapeutics-B Rises 6.27% in Regular Trading, Soochow Securities Initiates with Buy Rating and HK$418.61 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1198039714","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198039714?lang=en_us&edition=full_marsco","pubTime":"2026-07-10 09:48","pubTimestamp":1783648124,"startTime":"0","endTime":"0","summary":"On July 10, Duality Biotherapeutics-B (09606.HK) rose 6.27% in regular trading, trading at HK$215.2/share, with turnover of HK$35.54 million.The rally was driven by continued market reaction to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191425308","title":"Movement Alert｜Duality Biotherapeutics-B Rises 5.33% in Regular Trading, Soochow Securities Initiates with Buy Rating and HK$418.61 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1191425308","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191425308?lang=en_us&edition=full_marsco","pubTime":"2026-07-08 10:01","pubTimestamp":1783476070,"startTime":"0","endTime":"0","summary":"On July 8, Duality Biotherapeutics-B rose 5.33% in regular trading, trading at HK$222.0/share, with turnover of approximately HK$74.52 million.On the news front, Soochow Securities initiated coverage...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108116756","title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.07% in Regular Trading, Biotech Sector Faces Broad Profit-Taking Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1108116756","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108116756?lang=en_us&edition=full_marsco","pubTime":"2026-07-07 15:19","pubTimestamp":1783408787,"startTime":"0","endTime":"0","summary":"On July 7, Duality Biotherapeutics-B declined 5.07% in regular trading, trading at 213.4 HKD/share, with turnover of HKD 388 million. The pullback came after the stock posted substantial gains in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177976671","title":"Movement Alert｜Duality Biotherapeutics-B Rises 9.01% in Regular Trading, STAR Market IPO Status Upgraded to Inquired Amid ADC Sector Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1177976671","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177976671?lang=en_us&edition=full_marsco","pubTime":"2026-07-06 09:51","pubTimestamp":1783302687,"startTime":"0","endTime":"0","summary":"On July 6, Duality Biotherapeutics-B rose 9.01% in regular trading, trading at HK$232.0/share, with turnover of HK$105 million. The rally was driven by the company's STAR Market IPO review status...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160793891","title":"Movement Alert｜Duality Biotherapeutics-B Rises 6.31% in Regular Trading, ADC Sector Breakthroughs and STAR Market IPO Filing Continue to Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160793891","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160793891?lang=en_us&edition=full_marsco","pubTime":"2026-07-03 09:41","pubTimestamp":1783042890,"startTime":"0","endTime":"0","summary":"On July 3, Duality Biotherapeutics-B rose 6.31% in regular trading, trading at HKD 216.8/share, with turnover of approximately HKD 106 million. This follows a 15.01% surge the prior session.On the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":-0.0848},{"period":"1month","weight":-0.1516},{"period":"3month","weight":-0.1915},{"period":"6month","weight":-0.4682},{"period":"1year","weight":-0.474},{"period":"ytd","weight":-0.3883}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.037},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.0462},{"period":"1year","weight":0.0117},{"period":"ytd","weight":-0.0062}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.","exchange":"SEHK","name":"DUALITYBIO-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DUALITYBIO-B,09606,DUALITYBIO-B股票,DUALITYBIO-B股票老虎,DUALITYBIO-B股票老虎国际,DUALITYBIO-B行情,DUALITYBIO-B股票行情,DUALITYBIO-B股价,DUALITYBIO-B股市,DUALITYBIO-B股票价格,DUALITYBIO-B股票交易,DUALITYBIO-B股票购买,DUALITYBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}